Alkem Laboratories Overview
- Year Founded
-
1973
- Status
-
Public
- Employees
-
23,386
- Stock Symbol
-
ALKEM
- Investments
-
18
- Share Price
-
$55.05
- (As of Thursday Closing)
Alkem Laboratories General Information
Description
Alkem Laboratories Ltd is a diversified healthcare company engaged in the pharmaceutical business with operations. The Company is engaged in the development, manufacture, and sale of pharmaceutical products. It operates in one reportable business segment, Pharmaceuticals. Its operations include Domestic Pharma (Branded & Trade Generics, ActivLife and Alkem), Biotech (Biosimilars & Bio-CDMO), MedTech and Activa, and International Business. It focuses on chronic therapies, including anti-diabetes, dermatology, urology, and inhaled chronic respiratory. It caters to pharmaceutical firms, distributors, wholesalers, pharmacy chains, hospitals, and other healthcare-related institutional customers across domestic and international markets. It generates the maximum revenue from the United States.
Contact Information
Website
www.alkemlabs.comCorporate Office
- Devashish Building, Alkem House
- Senapati Bapat Road, Lower Parel
- Mumbai, 400013
- India
Corporate Office
- Devashish Building, Alkem House
- Senapati Bapat Road, Lower Parel
- Mumbai, 400013
- India
Alkem Laboratories Stock Performance
As of 19-Nov-2026, Alkem Laboratories’s stock price is $55.05. Its current market cap is $6.58B with 120M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $55.05 | $55.87 | $51.01 - $65.83 | $6.58B | 120M | 148K | $1.87 |
Alkem Laboratories Financials Summary
As of 30-Sep-2026, Alkem Laboratories has a trailing 12-month revenue of $1.69B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 6,272,506 | 6,438,544 | 6,479,174 | 6,846,847 |
| Revenue | 1,685,984 | 1,644,604 | 1,514,314 | 1,502,580 |
| EBITDA | 389,780 | 336,935 | 308,980 | 258,785 |
| Net Income | 223,016 | 260,491 | 256,096 | 216,918 |
| Total Assets | 2,400,765 | 2,212,230 | 2,068,184 | 1,867,640 |
| Total Debt | 240,462 | 216,969 | 161,435 | 170,086 |
Alkem Laboratories Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Alkem Laboratories Comparisons
Industry
Financing
Details
Alkem Laboratories Competitors (60)
One of Alkem Laboratories’s 60 competitors is Torrent Pharmaceuticals, a Corporation company based in Ahmedabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Corporation | Ahmedabad, India | ||||
| Cipla | Corporation | Mumbai, India | ||||
| Mankind Pharma | Formerly PE-Backed | New Delhi, India | ||||
| Marksans Pharma | Corporation | Mumbai, India | ||||
| Ajanta Pharma | Corporation | Mumbai, India |
Alkem Laboratories Patents
Alkem Laboratories Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240374527-A1 | Pharmaceutical composition comprising lumateperone | Pending | 08-May-2023 | ||
| WO-2024079748-A1 | Novel salts of aramchol and process thereof | Inactive | 13-Oct-2022 | ||
| EP-4577201-A1 | Mesdopetam compositions | Inactive | 24-Aug-2022 | ||
| US-20260053759-A1 | Mesdopetam compositions | Inactive | 24-Aug-2022 | ||
| WO-2024042540-A1 | Mesdopetam compositions | Inactive | 24-Aug-2022 | A61K31/145 |
Alkem Laboratories Signals
Alkem Laboratories Investments & Acquisitions (18)
Alkem Laboratories’s most recent deal was a Joint Venture with Alkem Pharma Company. The deal was made on 08-Nov-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Alkem Pharma Company | 08-Nov-2026 | Joint Venture | Pharmaceuticals | ||
| HaystackAnalytics | 13-Mar-2026 | Later Stage VC | Decision/Risk Analysis | ||
| Adroit Biomed | 23-Apr-2025 | Merger/Acquisition | Personal Products | ||
| Bombay Ortho Industries | 16-Apr-2025 | Merger/Acquisition | Other Devices and Supplies | ||
| Sahajanand Medical Technologies | 15-Oct-2024 | Merger/Acquisition | Surgical Devices |
Alkem Laboratories ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
29.29 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Alkem Laboratories Exits (1)
Alkem Laboratories’s most recent exit was on 28-Aug-2017 from Medlife. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Medlife | 28-Aug-2017 | Completed |
|
Alkem Laboratories Affiliates
Subsidiaries (5)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Adroit Biomed | Mumbai, India | 2012 | |
| S&b Pharma | Azusa, CA | 2012 | |
| Pharmacor | Sydney, Australia | 2007 | |
| Bombay Ortho Industries | Rajkot, India | 2002 | |
| Ascend Laboratories | Bedminster, NJ | 2000 |
Alkem Laboratories FAQs
-
When was Alkem Laboratories founded?
Alkem Laboratories was founded in 1973.
-
Where is Alkem Laboratories headquartered?
Alkem Laboratories is headquartered in Mumbai, India.
-
What is the size of Alkem Laboratories?
Alkem Laboratories has 23,386 total employees.
-
What industry is Alkem Laboratories in?
Alkem Laboratories’s primary industry is Pharmaceuticals.
-
Is Alkem Laboratories a private or public company?
Alkem Laboratories is a Public company.
-
What is Alkem Laboratories’s stock symbol?
The ticker symbol for Alkem Laboratories is ALKEM.
-
What is the current stock price of Alkem Laboratories?
As of 19-Nov-2026 the stock price of Alkem Laboratories is $55.05.
-
What is the current market cap of Alkem Laboratories?
The current market capitalization of Alkem Laboratories is $6.58B.
-
What is Alkem Laboratories’s current revenue?
The trailing twelve month revenue for Alkem Laboratories is $1.69B.
-
Who are Alkem Laboratories’s competitors?
Torrent Pharmaceuticals, Cipla, Mankind Pharma, Marksans Pharma, and Ajanta Pharma are some of the 60 competitors of Alkem Laboratories.
-
What is Alkem Laboratories’s annual earnings per share (EPS)?
Alkem Laboratories’s EPS for 12 months was $1.87.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process